MDS
Showing NaN - NaN of 19
Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or
Terminated
- Myelodysplastic Syndrome
- +3 more
- rigosertib
- +2 more
-
La Jolla, California
- +157 more
Sep 22, 2022
Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)
Not yet recruiting
- Hematologic Malignancy
- +10 more
- Tagraxofusp
- +8 more
-
Los Angeles, California
- +28 more
Jul 26, 2022
MDS, MDS Trial in Tampa, Boston, Houston (APR-548 + Azacitidine)
Terminated
- MDS
- Myelodysplastic Syndromes
- APR-548 + Azacitidine
-
Tampa, Florida
- +3 more
Jul 20, 2022
Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Canada, United States (CFI-400945, Azacitidine,
Recruiting
- Acute Myeloid Leukemia
- +5 more
- CFI-400945
- +2 more
-
Duarte, California
- +7 more
Jul 20, 2022
Relapsed/Refractory AML, AML, Adult, MDS Trial in United States (NKX101 - CAR NK cell therapy)
Recruiting
- Relapsed/Refractory AML
- +3 more
- NKX101 - CAR NK cell therapy
-
Denver, Colorado
- +6 more
Apr 8, 2022
AML, MDS Trial in United States (APVO436)
Recruiting
- AML
- MDS
- APVO436
-
San Francisco, California
- +11 more
Feb 8, 2022
Myelodysplastic Syndrome, MDS Trial in Canada, United States (ASTX727 Dose Escalation, ASTX727 Dose Confirmation, ASTX727
Completed
- Myelodysplastic Syndrome
- MDS
- ASTX727 Dose Escalation
- +2 more
-
Phoenix, Arizona
- +16 more
Dec 1, 2020
MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)
Completed
- Myelodysplastic Syndromes
- +3 more
- ON 01910.Na
-
Scottsdale, Arizona
- +86 more
Jun 29, 2020
Leukemia, AML, MDS Trial in Houston (Azacitidine)
Completed
- Leukemia
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 6, 2020
AML, ALL, Blast Crisis Trial in United States (TG02 citrate, Carfilzomib, Dexamethasone)
Completed
- AML
- +4 more
- TG02 citrate
- +2 more
-
Denver, Colorado
- +8 more
May 5, 2016
Leukemia, AML, MDS Trial in Houston (Cytarabine, Fludarabine)
Completed
- Leukemia
- +3 more
-
Houston, TexasUT MD Anderson Cancer Center
Feb 17, 2016
MDS, MDS Trial in Houston (Gimatecan)
Completed
- Myelodysplastic Syndromes
- MDS
-
Houston, TexasThe University of Texas M.D. Anderson Cancer Center
May 11, 2015